ABUS SG&A Expense Growth
Arbutus Biopharma Corp · SG&A Expense Growth
ABUS SG&A Expense Growth
Latest reported-28.11%period ending
ABUS FY SG&A Growth (YoY) (0.00% → -28.11%)
Latest values, visible window
High-resolution chart · PNG
ABUS sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -28.112% | |
| -1.6329% | |
| 26.0233% | |
| 4.0733% | |
| 15.4328% | |
| -16.2577% | |
| 10.7938% | |
| -0.6211% | |
| -59.1371% | |
| 49.0279% | |
| 203.8851% | |
| 56.8621% | |
| -79.3762% | |
| 334.9688% | |
| 29.3447% | |
| 20.5315% | |
| 9.5888% | |
| -18.5445% | |
| 15.2938% | |
| 1.8066% | |
| -51.2053% | |
| 14.3268% | |
| 22.8028% | |
| 78.1477% | |
| 37.5421% | |
| 43.8832% | |
| 17.7842% | |
| 0% |